The outcomes of SGLT-2 inhibitor utilization in diabetic kidney ...
1 day ago · SGLT-2i usage and outcomes in diabetic KTR. After a median follow-up of 3.4 years, the mortality rate among SGLT-2i users was significantly lower, with 2.08% (41 out of 1970, 6.56 per 1000 person ...
OFF
The Outcomes Of SGLT-2 Inhibitor Utilization In Diabetic Kidney ...
1 week from now
1 day ago · SGLT-2i usage and outcomes in diabetic KTR. After a median follow-up of 3.4 years, the mortality rate among SGLT-2i users was significantly lower, with 2.08% (41 out of 1970, 6.56 per 1000 person ...
nature.com
OFF
Randomized Trial Of SGLT2 Inhibitor Identifies Target Proteins In ...
1 week from now
DKD is among the most common diabetic complications affecting approximately 40% of persons with T2D. 1 Traditionally, DKD is treated with renin-angiotensin-system blockade. 2 However, …
nih.gov
OFF
Role And Mechanisms Of SGLT-2 Inhibitors In The Treatment Of …
1 week from now
Sep 21, 2023 · Diabetic kidney disease (DKD) is a chronic inflammatory condition that affects approximately 20-40% of individuals with diabetes. Sodium-glucose co-transporter 2 (SGLT-2) …
nih.gov
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
